Picture of Veracyte logo

VCYT Veracyte Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Veracyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-31-23-12.6-34.9-75.6
Depreciation
Deferred Taxes
Non-Cash Items8.696.2110.117.726.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.44-0.651-4.85-0.4814.22
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-23.9-13.5-3.23-9.71-31.6
Capital Expenditures-1.75-1.87-2.76-2.84-5.38
Purchase of Fixed Assets
Other Investing Cash Flow Items0.440-40-1-734
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-1.31-1.87-42.7-3.84-739
Financing Cash Flow Items-1.540.4030-3.85-9.03
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.21859.5127204596
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-25.444.181.3190-176

Or unlock with your email

Or unlock with your email